Grant opportunity · PAR-25-324
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
Who can apply (as listed)
- Others (see the opportunity text)
- Special district governments
- Small businesses
- Native American tribal governments (federally recognized)
- Independent school districts
- For-profit organizations (other than small businesses)
- Private institutions of higher education
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than federally recognized governments)
- City or township governments
- State governments
- County governments
- Public and state-controlled institutions of higher education
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and innovation and additional time to successfully launch their careers and to become more established before having to submit renewal applications (NOT-CA-18-037). The objective of the NCI's ESI MERIT Award is to allow eligible investigators the opportunity to obtain up to 7 years of support in two segments:
Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.
GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.